Lattice_grid_med
Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term Estrogens. Found 22 abstracts

no pagination
Choi HJ, Lui A, Ogony J, Jan R, Sims PJ, Lewis-Wambi J. Targeting interferon response genes sensitizes aromatase inhibitor resistant breast cancer cells to estrogen-induced cell death. Breast Cancer Res. 2015 Jan 15;17:6.   PMCID: 4336497
Peng J, Xu X, Mace BE, Vanderveer LA, Workman LR, Slifker MJ, Sullivan PM, Veenstra TD, Clapper ML. Estrogen metabolism within the lung and its modulation by tobacco smoke. Carcinogenesis. 2013 Apr;34(4):909-15.   PMCID: 3616670
Fernandez SV. Estrogen, alcohol consumption, and breast cancer. Alcoholism: Clinical and Experimental Research. 2011 Mar;35(3):389-91.   PMCID: not NIH funded
Ariazi EA, Brailoiu E, Yerrum S, Shupp HA, Slifker MJ, Cunliffe HE, Black MA, Donato AL, Arterburn JB, Oprea TI, Prossnitz ER, Dun NJ, Jordan VC. The G protein-coupled receptor GPR30 inhibits proliferation of estrogen receptor-positive breast cancer cells. Cancer Res. 2010 Feb;70(3):1184-94.   PMCID: PMC2879282
Meireles SI, Esteves GH, Hirata R, Peri S, Devarajan K, Slifker M, Mosier SL, Peng J, Vadhanam MV, Hurst HE, Neves EJ, Reis LF, Gairola CG, Gupta RC, Clapper ML. Early changes in gene expression induced by tobacco smoke: Evidence for the importance of estrogen within lung tissue. Cancer prevention research (Philadelphia, Pa). 2010 Jun;3(6):707-17.   PMCID: PMC2896420
Chen JQ, Cammarata PR, Baines CP, Yager JD. Regulation of mitochondrial respiratory chain biogenesis by estrogens/estrogen receptors and physiological, pathological and pharmacological implications. Biochim Biophys Acta. 2009 Oct;1793(10):1540-70.   PMCID: PMC2744640
Jordan VC, Lewis-Wambi JS, Patel RR, Kim H, Ariazi EA. New hypotheses and opportunities in endocrine therapy: amplification of oestrogen-induced apoptosis. Breast. 2009 Oct;18 Suppl 3:S10-7.   PMCID: PMC2867601
Kocdor H, Kocdor MA, Russo J, Snider KE, Vanegas JE, Russo IH, Fernandez SV. Human chorionic gonadotropin (hCG) prevents the transformed phenotypes induced by 17 beta-estradiol in human breast epithelial cells. Cell Biol Int. 2009 Nov;33(11):1135-43.   PMCID: PMC2783498
Lewis-Wambi JS, Jordan VC. Estrogen regulation of apoptosis: how can one hormone stimulate and inhibit?. Breast Cancer Res. 2009 Jan;11(3):206.   PMCID: PMC2716493
Hwang C, Giri VN, Wilkinson JC, Wright CW, Wilkinson AS, Cooney KA, Duckett CS. EZH2 regulates the transcription of estrogen-responsive genes through association with REA, an estrogen receptor corepressor. Breast Cancer Res Treat. 2008 Jan;107(2):235-42.
Jordan VC. The 38th David A. Karnofsky lecture: the paradoxical actions of estrogen in breast cancer--survival or death?. J Clin Oncol. 2008 Jun 20;26(18):3073-82.
Swaby RF, Jordan VC. Low-dose estrogen therapy to reverse acquired antihormonal resistance in the treatment of breast cancer. Clin Breast Cancer. 2008 Apr;8(2):124-33.
Ariazi EA, Kraus RJ, Farrell ML, Jordan VC, Mertz JE. Estrogen-related receptor alpha1 transcriptional activities are regulated in part via the ErbB2/HER2 signaling pathway. Molecular cancer research : MCR. 2007 Jan;5(1):71-85.
Chen JQ, Russo PA, Cooke C, Russo IH, Russo J. ERbeta shifts from mitochondria to nucleus during estrogen-induced neoplastic transformation of human breast epithelial cells and is involved in estrogen-induced synthesis of mitochondrial respiratory chain proteins. Biochim Biophys Acta. 2007 Dec;1773(12):1732-46.
Craig Jordan V, Lewis-Wambi J, Kim H, Cunliffe H, Ariazi E, Sharma CG, Shupp HA, Swaby R. Exploiting the apoptotic actions of oestrogen to reverse antihormonal drug resistance in oestrogen receptor positive breast cancer patients. Breast. 2007 Dec;16 Suppl 2:S105-13.
Cavalieri EL, Devanesan P, Bosland MC, Badawi AF, Rogan EG. Catechol estrogen metabolites and conjugates in different regions of the prostate of Noble rats treated with 4-hydroxyestradiol: implications for estrogen-induced initiation of prostate cancer. Carcinogenesis. 2002 Feb;23(2):329-33.
Russo J, Lareef H, Tahin Q, Russo IH. Pathways of carcinogenesis and prevention in the human breast. Eur J Cancer. 2002 Sep;38 Suppl 6:31-2.
Russo J, Tahin Q, Lareef MH, Hu YF, Russo IH. Neoplastic transformation of human breast epithelial cells by estrogens and chemical carcinogens. Environ Mol Mutagen. 2002 Jan;39(2-3):254-63.
Russo J, Hu YF, Tahin Q, Mihaila D, Slater C, Lareef MH, Russo IH. Carcinogenicity of estrogens in human breast epithelial cells. APMIS. 2001 Jan;109(1):39-52.
Zhang Y, Felson DT, Ellison RC, Kreger BE, Schatzkin A, Dorgan JF, Cupples LA, Levy D, Kiel DP. Bone mass and the risk of colon cancer among postmenopausal women: the Framingham study. Am J Epidemiol. 2001 Jan;153(1):31-7.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term Estrogens

Estrogens Female Breast Neoplasms metabolism drug effects pharmacology Estradiol genetics physiology Signal Transduction Estrogen Receptors etiology drug therapy Neoplasm Drug Resistance pathology Breast Mice Cell Proliferation Neoplastic Gene Expression Regulation US Gov't Support-PHS Apoptosis Tumor Cell Line Human Epithelial Cells Selective Estrogen Receptor Modulators Genetic Transcription Aromatase Inhibitors Cell Differentiation Neoplastic Cell Transformation Male Messenger RNA Lung Neoplasms Electron Transport Aryl Hydrocarbon Hydroxylases cytology Carcinogens therapeutic use Lung Estrogen Receptor alpha Time Factors biosynthesis G-Protein-Coupled Receptors Mitochondrial Proteins chemically induced enzymology Hormonal Antineoplastic Agents Mitochondria analogs & derivatives Biological Models Progesterone Receptors RNA Interference Protein Transport Tamoxifen Animal Catechol O-Methyltransferase adverse effects Cell Line Diethylstilbestrol Hormone-Dependent Neoplasms Bone Density Biological Markers Subcellular Fractions Nitriles Adult Alcohol Drinking Patterns Mitochondrial Proton-Translocating ATPases epidemiology Tobacco Smoke Pollution Middle Age Gene Expression Profiling Estrogen Replacement Therapy Electrophoretic Mobility Shift Assay Disease Progression Rats Genotype toxicity 80 and over Aged Drug Delivery Systems Enzyme Induction Postmenopause Colony-Forming Units Assay Protein Biosynthesis Cryptochromes Urethra Glutathione Presenilin-2 Clinical Trials as Topic Oligonucleotide Array Sequence Analysis Immunohistochemistry Massachusetts Neuroprotective Agents Microsomes Differentiation Antigens Incidence Propionates Prostatic Neoplasms Cyclin-Dependent Kinase Inhibitor p21 DNA-Binding Proteins Reverse Transcriptase Polymerase Chain Reaction Gene Silencing Menopause Transformed Cell Line Phosphorylation Epidermal Growth Factor Receptor methods physiopathology Colonic Neoplasms history Drug Therapy Cell Division Cell Death Nuclear Receptor Coactivator 2 Genetic Transformation STAT2 Transcription Factor Reproductive Control Agents Triglycerides NAD(P)H Dehydrogenase (Quinone) Testosterone US Gov't Support-Non-PHS Quinolines STAT1 Transcription Factor Cultured Tumor Cells Knockout Mice Interferons Raloxifene Octanoic Acids analogs & Estrogen Receptor beta Atmosphere Exposure Chambers Non-US Gov't Support Protein Binding Intracellular Space Drug Dose-Response Relationship Repressor Proteins Gene Expression Regulation ultrastructure Crystalline Lens Fluorescence Microscopy 20th Century History chemistry Calcium Genetic Enhancer Elements Excipients Cardiovascular Diseases erbB-2 Receptor Smoke Aged trends Chorionic Gonadotropin Mitogen-Activated Protein Kinase Kinases
Last updated on Tuesday, October 10, 2017